| Indication: | For the treatment of Wilson’s disease (hepatolenticular degeneration) in patients intolerant to Penicillamine. It should be used when continued treatment with Penicillamine is no longer possible because of intolerable or life endangering side effect. |
|---|---|
| Dosage Form: | Capsule |
| Storage Conditions: | Store at room temperature (not above 30⁰C) in the original container. |
| Each Capsule contains 333 mg Trientine Tetrahydrochloride equivalent to 167 mg of Trientine base or 250 mg of Trientine hydrochloride. |
Disclaimer
Healthcare Professional
